Should You Buy AstraZeneca plc (AZN) in Drug Manufacturers - General Industry?

2022-05-22 00:23:32 By : Ms. Marcia Yang

AstraZeneca plc (AZN) leads the Drug Manufacturers - General industry with an overall score of 79. AZN is up 12.99% so far this year after the company closed yesterday at $63.14. The overall score measures the company's performance based-off both short and long term indicators and means that AZN scores better than 79% of the overall market. AZN has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on AZN! See Full AZN Report AstraZeneca plc is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 51. This means that, on average, the stocks in this industry score higher than 51% of the stock market. To see InvestorsObserver's Sentiment Score for AstraZeneca plc click here. AZN has been trading neutral recently. The stock is trading up 0.89% this week following yesterday's decline. AZN has an average analyst ranking of Strong Buy with an average price target of $74.25. Click Here to get the full Stock Report for AstraZeneca plc stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

Thank you for signing up! You're all set to receive the Morning Update newsletter

Stock Price data may be delayed up to 15 minutes.

Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy